Department of Trauma, Medical University of Vienna
Vienna, Austria, 1090
NCT Number: NCT02074969
The purpose of this study is to assess the differences between two different types of devices for the treatment of unstable pertrochanteric hip fractures. The hypothesis of this study is, that patients who are treated with the proximal femoral Nail Antirotation (PFNA) have a better outcome and lower complication rates than patients treated with the Gamma Nail (GN3).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Vienna, Austria, 1090
This trial is a prospective randomized controlled study including the treatment of AO/OTA 31-A2 fractures in 200 patients with 2 different surgical devices. 100 patients are treated with a Gamma Nail 3 (GN3) (Stryker) the other 100 patients with a Proximal Femoral Nail Antirotation (PFNA) (Synthes).
All surgeries are performed by trauma surgeons at a Level 1 University Hospital. One hundred patients are randomized to the gamma nail and 100 are randomized to the proximal femoral nail for treatment fixation. A 1:1 randomization is performed using sealed envelopes (200 in total), which are opened by the surgeon immediately before the operation.
Patients missing an informed consent form, incomplete chart, or showing a pathologic fracture are getting excluded from final comparisons.
Patients anthropometric data as well as pre-injury mobility assessments, and ASA will be documented. Furthermore the time from admission to going to surgery, surgery length, length of stay and mobility assessment at dischargement are recorded.
After surgery the stay in the hospital is documented precisely and patients are scheduled for next appointments 2 weeks, 6 weeks, 3 months, 6 months and 1 year after surgery.
Postoperative X-rays are measured precisely to determine the Tip-Apex Distance (TAD), the Parkers-Ratio, the Singh-Score and the Neck-Shaft-Angle of the injured and contralateral side. Rates of complications as cut-out and reoperation-rates are evaluated. All intra-operative complications are noted and included in the chart.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by Gamma Nail 3.
Other names: Gamma Nail 3 Stryker
Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by PFNA.
Other names: PFNA Antirotation Synthes
Time frame: time between intervention and one year after
Time frame: time between intervention and one year after
evaluation of sliding movements of the hip screw in the sense of a cut-out
Time frame: time between hospitalization and one year after intervention
Mobility assessment includes scoring of pre-operative level of mobility and mobility after intervention
Medical University of Vienna
Other
Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures - Epidemiological Data and Rates of Complications
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01704859
Fractures, Fractures, Bone
Boston, Massachusetts, United States
View Trial DetailsNCT06644391
Fractures, Fractures, Bone
Frýdek-Místek, Moravian-Silesian Region, Czechia
View Trial DetailsNCT06783205
Dexterity, Fractures
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT07401953
Fractures, Fractures, Bone
View Trial Details